Douglas Godshall - May 27, 2022 Form 4 Insider Report for Shockwave Medical, Inc. (SWAV)

Role
President & CEO, Director
Signature
/s/ Wade Estey, as attorney-in-fact for Douglas Godshall
Stock symbol
SWAV
Transactions as of
May 27, 2022
Transactions value $
-$446,274
Form type
4
Date filed
6/1/2022, 07:01 PM
Previous filing
May 13, 2022
Next filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Options Exercise $8.88K +2.6K +1.82% $3.42* 146K May 27, 2022 Direct F1
transaction SWAV Common Stock Sale -$455K -2.6K -1.79% $175.06 143K May 27, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Stock Option Options Exercise $0 -2.6K -0.56% $0.00 462K May 27, 2022 Common Stock 2.6K $3.42 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $175.00 to $175.26. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 Twenty-Five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares are scheduled to vest in equal monthly installments thereafter for 36 months.